SCHEMBL4922691

SCHEMBL4922691

Cn1cc(S(=O)(=O)N2Cc3cn[nH]c3-c3cc(CF)ccc32)cn1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSEN1 P49768 10/20 0.55
▸ PSEN2 P49810 10/20 0.55
▸ APH1B Q8WW43 10/20 0.55
▸ NCSTN Q92542 10/20 0.55
▸ APH1A Q96BI3 10/20 0.55
▸ PSENEN Q9NZ42 10/20 0.55
▸ MAP4K4 O95819 1/20 0.36
▸ CHEK2 O96017 1/20 0.36
▸ FYN P06241 1/20 0.36
▸ YES1 P07947 1/20 0.36
▸ FGR P09769 1/20 0.36
▸ KIT P10721 1/20 0.36
▸ MAP3K9 P80192 1/20 0.36
▸ MAP2K1 Q02750 1/20 0.36
▸ PTK2 Q05397 1/20 0.36
▸ MAP4K2 Q12851 1/20 0.36
▸ PTK2B Q14289 1/20 0.36
▸ MYLK Q15746 1/20 0.36
▸ AURKB Q96GD4 1/20 0.36
▸ BRS3 P32247 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2705438 0.72 PSEN1 (0.83) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL2704668 0.71 PSEN1 (1.00) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL2704628 0.71 PSEN1 (0.72) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4922696 0.68 PSEN1 (0.48) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL9537579 0.67 PSEN1 (0.61) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL8231871 0.67 PSEN1 (0.80) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL9540819 0.66 PSEN1 (0.64) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL2704878 0.66 PSEN1 (0.71) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL2702617 0.66 PSEN1 (1.00) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL2705222 0.65 PSEN1 (1.00) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080021056-A1 Fused, Tricyclic Sulfonamide Inhibitors of Gamma Secretase ELAN PHARMACEUTICALS, INC. 2008-01-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021056-A1 Fused, Tricyclic Sulfonamide Inhibitors of Gamma Secretase BACE1, BACE2, PSEN1 PSEN1 3/4885PSEN2 7/4885APH1B 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback